| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
12 companies
Gordon Carl L is a Director at NTLA, with reported holdings spanning 12 companies. Recent filings cover 42 purchases and 23 sales. Those positions are worth an estimated $198.3M at current prices.
Our model assigns Gordon Carl L a strong insider score of 74/100, based on 34 past trades. Over a 12-month horizon, 82.4% of those trades were profitable, with an average 12-month return of +47.7%.
Gordon Carl L's largest disclosed position is in MBX as Director, 10% Owner, worth about $49.4M. Net of sales, the recent Form 4 record there shows accumulation of 940,672 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2022 | CMPX Compass Therapeutics, Inc. | Director, 10% Owner | Buy | 402,000 | $3.21 | $1,290,420.00 | +2.7% | -7.3% | -59.5% | |
| Aug 16, 2022 | TERN Terns Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 3,690,000 | $2.42 | $8,929,800.00 | +97.3% | -7.2% | +14.3% | |
| May 13, 2022 | CMPX Compass Therapeutics, Inc. | Director, 10% Owner | Buy | 192,516 | $2.18 | $420,481.68 | +0.4% | +8.3% | +28.1% | |
| May 10, 2022 | CMPX Compass Therapeutics, Inc. | Director, 10% Owner | Buy | 125,359 | $1.57 | $197,251.92 | +0.3% | +58.5% | +105.5% | |
| Nov 4, 2021 | CMPX Compass Therapeutics, Inc. | Director, 10% Owner | Buy | 5,357,143 | $3.50 | $18,750,000.50 | +42.1% | -55.7% | +14.3% | |
| Mar 30, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 103,424 | $23.48 | $2,428,092.22 | -2.3% | -23.8% | -77.0% | |
| Mar 26, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 112,298 | $24.53 | $2,754,247.38 | -1.6% | -23.6% | -80.9% | |
| Mar 23, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 32,940 | $26.21 | $863,339.00 | -0.4% | -21.5% | -78.6% | |
| Mar 18, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 66,202 | $27.95 | $1,850,338.63 | -0.9% | -29.1% | -74.7% | |
| Mar 15, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 238,282 | $30.54 | $7,275,985.53 | -2.9% | -30.5% | -78.4% |